Your browser doesn't support javascript.
loading
Inhibitory effects of cyanidin-3-O-glucoside in black soybean hull extract on RBL-2H3 cells degranulation and passive cutaneous anaphylaxis reaction in mice.
Hiemori-Kondo, Miki; Morikawa, Etsuko; Fujikura, Michiko; Nagayasu, Ayuko; Maekawa, Yuuki.
Affiliation
  • Hiemori-Kondo M; Department of Food Nutritional Science, Tokushima Bunri University, 180 Nishihama, Yamashiro, Tokushima 770-8514, Japan; Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan. Electronic address: m-kondo@tks.bunri-u.ac.jp.
  • Morikawa E; Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan.
  • Fujikura M; Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan.
  • Nagayasu A; Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama 719-1197, Japan.
  • Maekawa Y; Department of Food Nutritional Science, Tokushima Bunri University, 180 Nishihama, Yamashiro, Tokushima 770-8514, Japan.
Int Immunopharmacol ; 94: 107394, 2021 May.
Article in En | MEDLINE | ID: mdl-33582590
ABSTRACT
Black soybean hull extract (BSHE) exhibits a variety of biological activities. However, little is known about the effects of BSHE on immunoglobulin E (IgE)-mediated type I allergic reactions. The anti-allergic effect of BSHE was assessed with the degranulation assay using rat basophilic leukemia RBL-2H3 cells and the passive cutaneous anaphylaxis (PCA) reaction in mice. An active compound in BSHE was identified by ultra-performance liquid chromatography coupled to diode array detection and electrospray ionization tandem mass spectrometry analysis. BSHE inhibited the release of ß-hexosaminidase and histamine in RBL-2H3 cells, and cyanidin-3-O-glucoside (C3G) was identified as one of its active compounds. Oral administering of 200 µmol/kg of C3G to IgE-sensitized mice prior to antigen injection suppressed the PCA reaction, as compared with control (p < 0.01). Intravenous administration of BSHE (C3G content, 5.4%) more strongly inhibited PCA responses at lower doses (100 mg/kg, p < 0.01) than oral administration (1,000 mg/kg, p = 0.059). Intravenous C3G also suppressed PCA response at a low dose (40 mg/kg, p < 0.05), showing the same trend as BSHE. This information can be useful to design appropriate formulations of anthocyanin-based drug products to suppress allergic reactions. This study provides evidence for the potential use of BSHE and C3G for the prevention or the treatment of type I allergies.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Passive Cutaneous Anaphylaxis / Cell Degranulation / Anthocyanins Language: En Journal: Int Immunopharmacol Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Passive Cutaneous Anaphylaxis / Cell Degranulation / Anthocyanins Language: En Journal: Int Immunopharmacol Year: 2021 Type: Article